Atherectomy and Thrombectomy Devices Market Size, Trends, Analysis, and Outlook By Product (Atherectomy Devices, Thrombectomy Devices), By End-User (Hospitals, Ambulatory Surgical Centers, Research Laboratories and Academic Institutes), by Region, Country, Segment, and Companies, 2024-2030
The global Atherectomy and Thrombectomy Devices market size is poised to register 6.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Atherectomy and Thrombectomy Devices market across By Product (Atherectomy Devices, Thrombectomy Devices), By End-User (Hospitals, Ambulatory Surgical Centers, Research Laboratories and Academic Institutes).
The Atherectomy and Thrombectomy Devices Market are witnessing significant growth and technological innovation driven by the increasing prevalence of peripheral artery disease (PAD), thrombotic disorders, and the demand for minimally invasive endovascular interventions to treat arterial occlusions, remove thrombi, and restore blood flow in diseased arteries and veins. Atherectomy and thrombectomy devices encompass a range of catheter-based technologies, including rotational atherectomy, laser atherectomy, and mechanical thrombectomy systems, designed to debulk atherosclerotic plaques, dissolve blood clots, and recanalize occluded blood vessels to improve limb perfusion and alleviate symptoms of claudication, ischemia, and critical limb-threatening ischemia (CLI). Key trends include the development of next-generation atherectomy and thrombectomy devices, drug-coated balloon angioplasty, and drug-eluting stent technologies to optimize treatment outcomes, reduce restenosis rates, and prevent recurrent thrombotic events in patients with PAD and thromboembolic disorders. Additionally, there is a growing emphasis on multidisciplinary vascular care teams, patient-centered care pathways, and value-based reimbursement models to promote coordinated vascular interventions, optimize resource utilization, and improve clinical outcomes and quality of life for individuals with peripheral vascular diseases. Moreover, collaborative vascular research networks, clinical trial registries, and quality improvement initiatives are essential for generating real-world evidence, advancing endovascular innovation, and driving continuous improvement in atherectomy and thrombectomy technologies, enhancing vascular care delivery and patient outcomes in the management of arterial and venous thrombotic disorders worldwide.
Atherectomy and Thrombectomy Devices Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Atherectomy and Thrombectomy Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Atherectomy and Thrombectomy Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Atherectomy and Thrombectomy Devices industry.
Key market trends defining the global Atherectomy and Thrombectomy Devices demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Atherectomy and Thrombectomy Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Atherectomy and Thrombectomy Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Atherectomy and Thrombectomy Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Atherectomy and Thrombectomy Devices industry
Leading Atherectomy and Thrombectomy Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Atherectomy and Thrombectomy Devices companies.
Atherectomy and Thrombectomy Devices Market Study- Strategic Analysis Review
The Atherectomy and Thrombectomy Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Atherectomy and Thrombectomy Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Atherectomy and Thrombectomy Devices Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Atherectomy and Thrombectomy Devices Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Atherectomy and Thrombectomy Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Atherectomy and Thrombectomy Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Atherectomy and Thrombectomy Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Atherectomy and Thrombectomy Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Atherectomy and Thrombectomy Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Atherectomy and Thrombectomy Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Atherectomy and Thrombectomy Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Atherectomy and Thrombectomy Devices in Asia Pacific. In particular, China, India, and South East Asian Atherectomy and Thrombectomy Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Atherectomy and Thrombectomy Devices Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Atherectomy and Thrombectomy Devices Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Atherectomy and Thrombectomy Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Atherectomy and Thrombectomy Devices.
Atherectomy and Thrombectomy Devices Market Company Profiles
The global Atherectomy and Thrombectomy Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Argon Medical Devices, Bayer AG, Boston Scientific Corp, Cardiovascular Systems Inc, Covidien PLC, Getinge AB, Sorin Group USA Inc, Spectranetics Corp, Spectranetics Corp, St. Jude Medical Inc, Straub Medical AG, Terumo Medical Corp, Uscom Ltd, Vascular Solutions Inc, Ventracor Ltd, Zoll Medical Corp
Recent Atherectomy and Thrombectomy Devices Market Developments
The global Atherectomy and Thrombectomy Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Atherectomy and Thrombectomy Devices Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes
Geographical Segmentation:
Argon Medical Devices
Bayer AG
Boston Scientific Corp
Cardiovascular Systems Inc
Covidien PLC
Getinge AB
Sorin Group USA Inc
Spectranetics Corp
Spectranetics Corp
St. Jude Medical Inc
Straub Medical AG
Terumo Medical Corp
Uscom Ltd
Vascular Solutions Inc
Ventracor Ltd
Zoll Medical Corp
Formats Available: Excel, PDF, and PPT
The Atherectomy and Thrombectomy Devices Market are witnessing significant growth and technological innovation driven by the increasing prevalence of peripheral artery disease (PAD), thrombotic disorders, and the demand for minimally invasive endovascular interventions to treat arterial occlusions, remove thrombi, and restore blood flow in diseased arteries and veins. Atherectomy and thrombectomy devices encompass a range of catheter-based technologies, including rotational atherectomy, laser atherectomy, and mechanical thrombectomy systems, designed to debulk atherosclerotic plaques, dissolve blood clots, and recanalize occluded blood vessels to improve limb perfusion and alleviate symptoms of claudication, ischemia, and critical limb-threatening ischemia (CLI). Key trends include the development of next-generation atherectomy and thrombectomy devices, drug-coated balloon angioplasty, and drug-eluting stent technologies to optimize treatment outcomes, reduce restenosis rates, and prevent recurrent thrombotic events in patients with PAD and thromboembolic disorders. Additionally, there is a growing emphasis on multidisciplinary vascular care teams, patient-centered care pathways, and value-based reimbursement models to promote coordinated vascular interventions, optimize resource utilization, and improve clinical outcomes and quality of life for individuals with peripheral vascular diseases. Moreover, collaborative vascular research networks, clinical trial registries, and quality improvement initiatives are essential for generating real-world evidence, advancing endovascular innovation, and driving continuous improvement in atherectomy and thrombectomy technologies, enhancing vascular care delivery and patient outcomes in the management of arterial and venous thrombotic disorders worldwide.
Atherectomy and Thrombectomy Devices Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Atherectomy and Thrombectomy Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Atherectomy and Thrombectomy Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Atherectomy and Thrombectomy Devices industry.
Key market trends defining the global Atherectomy and Thrombectomy Devices demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Atherectomy and Thrombectomy Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Atherectomy and Thrombectomy Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Atherectomy and Thrombectomy Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Atherectomy and Thrombectomy Devices industry
Leading Atherectomy and Thrombectomy Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Atherectomy and Thrombectomy Devices companies.
Atherectomy and Thrombectomy Devices Market Study- Strategic Analysis Review
The Atherectomy and Thrombectomy Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Atherectomy and Thrombectomy Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Atherectomy and Thrombectomy Devices Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Atherectomy and Thrombectomy Devices Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Atherectomy and Thrombectomy Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Atherectomy and Thrombectomy Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Atherectomy and Thrombectomy Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Atherectomy and Thrombectomy Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Atherectomy and Thrombectomy Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Atherectomy and Thrombectomy Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Atherectomy and Thrombectomy Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Atherectomy and Thrombectomy Devices in Asia Pacific. In particular, China, India, and South East Asian Atherectomy and Thrombectomy Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Atherectomy and Thrombectomy Devices Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Atherectomy and Thrombectomy Devices Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Atherectomy and Thrombectomy Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Atherectomy and Thrombectomy Devices.
Atherectomy and Thrombectomy Devices Market Company Profiles
The global Atherectomy and Thrombectomy Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Argon Medical Devices, Bayer AG, Boston Scientific Corp, Cardiovascular Systems Inc, Covidien PLC, Getinge AB, Sorin Group USA Inc, Spectranetics Corp, Spectranetics Corp, St. Jude Medical Inc, Straub Medical AG, Terumo Medical Corp, Uscom Ltd, Vascular Solutions Inc, Ventracor Ltd, Zoll Medical Corp
Recent Atherectomy and Thrombectomy Devices Market Developments
The global Atherectomy and Thrombectomy Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Atherectomy and Thrombectomy Devices Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Argon Medical Devices
Bayer AG
Boston Scientific Corp
Cardiovascular Systems Inc
Covidien PLC
Getinge AB
Sorin Group USA Inc
Spectranetics Corp
Spectranetics Corp
St. Jude Medical Inc
Straub Medical AG
Terumo Medical Corp
Uscom Ltd
Vascular Solutions Inc
Ventracor Ltd
Zoll Medical Corp
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Atherectomy and Thrombectomy Devices Market Overview and Key Findings, 2024
1.2 Atherectomy and Thrombectomy Devices Market Size and Growth Outlook, 2021- 2030
1.3 Atherectomy and Thrombectomy Devices Market Growth Opportunities to 2030
1.4 Key Atherectomy and Thrombectomy Devices Market Trends and Challenges
1.4.1 Atherectomy and Thrombectomy Devices Market Drivers and Trends
1.4.2 Atherectomy and Thrombectomy Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Atherectomy and Thrombectomy Devices Companies
2. ATHERECTOMY AND THROMBECTOMY DEVICES MARKET SIZE OUTLOOK TO 2030
2.1 Atherectomy and Thrombectomy Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Atherectomy and Thrombectomy Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ATHERECTOMY AND THROMBECTOMY DEVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ATHERECTOMY AND THROMBECTOMY DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Atherectomy and Thrombectomy Devices Market, 2025
5.2 Asia Pacific Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Atherectomy and Thrombectomy Devices Market, 2025
5.5 Europe Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Atherectomy and Thrombectomy Devices Market, 2025
5.8 North America Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Atherectomy and Thrombectomy Devices Market, 2025
5.11 South America Pacific Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Atherectomy and Thrombectomy Devices Market, 2025
5.14 Middle East Africa Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Atherectomy and Thrombectomy Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
7. ATHERECTOMY AND THROMBECTOMY DEVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ATHERECTOMY AND THROMBECTOMY DEVICES COMPANY PROFILES
8.1 Profiles of Leading Atherectomy and Thrombectomy Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Argon Medical Devices
Bayer AG
Boston Scientific Corp
Cardiovascular Systems Inc
Covidien PLC
Getinge AB
Sorin Group USA Inc
Spectranetics Corp
Spectranetics Corp
St. Jude Medical Inc
Straub Medical AG
Terumo Medical Corp
Uscom Ltd
Vascular Solutions Inc
Ventracor Ltd
Zoll Medical Corp
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Atherectomy and Thrombectomy Devices Market Overview and Key Findings, 2024
1.2 Atherectomy and Thrombectomy Devices Market Size and Growth Outlook, 2021- 2030
1.3 Atherectomy and Thrombectomy Devices Market Growth Opportunities to 2030
1.4 Key Atherectomy and Thrombectomy Devices Market Trends and Challenges
1.4.1 Atherectomy and Thrombectomy Devices Market Drivers and Trends
1.4.2 Atherectomy and Thrombectomy Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Atherectomy and Thrombectomy Devices Companies
2. ATHERECTOMY AND THROMBECTOMY DEVICES MARKET SIZE OUTLOOK TO 2030
2.1 Atherectomy and Thrombectomy Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Atherectomy and Thrombectomy Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ATHERECTOMY AND THROMBECTOMY DEVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ATHERECTOMY AND THROMBECTOMY DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Atherectomy and Thrombectomy Devices Market, 2025
5.2 Asia Pacific Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Atherectomy and Thrombectomy Devices Market, 2025
5.5 Europe Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Atherectomy and Thrombectomy Devices Market, 2025
5.8 North America Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Atherectomy and Thrombectomy Devices Market, 2025
5.11 South America Pacific Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Atherectomy and Thrombectomy Devices Market, 2025
5.14 Middle East Africa Atherectomy and Thrombectomy Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Atherectomy and Thrombectomy Devices Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Atherectomy and Thrombectomy Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Atherectomy and Thrombectomy Devices Industry Drivers and Opportunities
7. ATHERECTOMY AND THROMBECTOMY DEVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ATHERECTOMY AND THROMBECTOMY DEVICES COMPANY PROFILES
8.1 Profiles of Leading Atherectomy and Thrombectomy Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Argon Medical Devices
Bayer AG
Boston Scientific Corp
Cardiovascular Systems Inc
Covidien PLC
Getinge AB
Sorin Group USA Inc
Spectranetics Corp
Spectranetics Corp
St. Jude Medical Inc
Straub Medical AG
Terumo Medical Corp
Uscom Ltd
Vascular Solutions Inc
Ventracor Ltd
Zoll Medical Corp
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
